{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of a worldwide exclusive evaluation option license, to practice the inventions embodied in US patent application 13/180,111, filed July 11, 2011 (HHS Reference<greek-i> E-205-2010/0-US-02), originated from provisional application 61/363,079 filed July 09, 2010, and entitled \"Photosensitizing Antibody Fluorophore Conjugates for Photo- Immunotherapy\" to Aspyrian Therapeutics, Inc., a company incorporated under the laws of the State of Delaware, having its headquarters in San Diego, California. The United States of America is the assignee of the rights of the above inventions. The field of use may be limited to \"use of photosensitizing antibody-fluorophore conjugate for imaging and photo-immunotherapy of cancer\" and may be further limited to certain types of cancer and/or specific platforms. Upon the expiration or termination of the exclusive evaluation option license, Aspyrian Therapeutics, Inc. will have the right to execute an exclusive worldwide patent commercialization license which will supersede and replace the exclusive evaluation option license with the same field of use.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2012/02/17/2012-3828.html","cfr_references":[],"citation":"77 FR 9678","comment_url":null,"comments_close_on":"2012-03-05","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license received by the NIH Office of Technology Transfer on or before March 5, 2012 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2012-3828","effective_on":null,"end_page":9678,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2012/02/17/2012-3828.xml","html_url":"https://www.federalregister.gov/documents/2012/02/17/2012-3828/prospective-grant-of-exclusive-license-photosensitizing-antibody-fluorophore-conjugates-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2012-3828?publication_date=2012-02-17","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2012-02-17/2012-3828/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":124,"last_updated":"2026-11-22 14:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2012-02-17/pdf/2012-3828.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2012-03828.pdf?1329400417","publication_date":"2012-02-17","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2012/02/17/2012-3828.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2012-04-13T23:44:17Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":9678,"subtype":null,"title":"Prospective Grant of Exclusive License: Photosensitizing Antibody-Fluorophore Conjugates for Photo-Immunotherapy","toc_doc":"Photosensitizing Antibody-Fluorophore Conjugates for Photo-Immunotherapy","toc_subject":"Prospective Grant of Exclusive License:","topics":[],"type":"Notice","volume":77}